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Background: Seminomas in the dog have traditionally been assumed to resemble human spermatocytic
seminomas, based on their low malignancy and high occurrence in old individuals. However, recently published
studies indicate that canine seminomas can be classified as classical and spermatocytic seminomas in a similar way
as in man, and that classical seminomas comprise a substantial proportion of seminomas in the dog. These two
factors both contribute to increasing the potential of canine seminoma as a relevant model for human testicular
cancer. The aim of the present study was to characterise seminoma in Norwegian dogs using morphology and
immunohistochemistry, and determine whether these tumours are comparable with human classical seminoma.
Methods: By applying diagnostic criteria from human pathology, 45 seminomas from the Norwegian Canine
Cancer Register were examined histologically with hematoxylin and eosin (HE) and periodic acid-Schiff (PAS) stains.
All sections were stained immunohistochemically with antibodies against human placental alkaline phosphatase
(PLAP) and the transmembrane receptor c-KIT.
Results: Although two of the seminomas showed immunohistochemical staining characteristics indicative of
classical seminoma (PLAP+/c-KIT+), all 45 examined seminomas were morphologically consistent with
spermatocytic seminoma.
Conclusions: The value of canine seminoma as a model for SE in man remains unclear. Among the 45 investigated
tumours from Norwegian dogs, none were classified as classical seminoma based on morphological criteria
consistent with human seminomas. Regional or breed differences in the occurrence of classical seminoma in the
dog, as well as the lack of uniform diagnostic criteria, might explain the discrepancy between the findings in the
current study and the results presented by other authors.
Keywords: Dog, Seminoma, Testis, TumourBackground
The vast majority of human testicular tumours are
germ cell neoplasms. These are histologically classified
as seminomas and non-seminomas [1]. The WHO clas-
sification of testicular tumours in man includes two
types of seminoma: classical seminoma (SE) and sper-
matocytic seminoma (SS) [2]. SE is the most common
malignant tumour among young men, with a peak inci-
dence between the ages of 25 and 35 years. Norway
has one of the highest incidences of testicular germ
cell tumours in the world with 11.7 cases per 100,000
person-years (age-standardised rates (world) 2005–09) [3].* Correspondence: gjermund.gunnes@nvh.no
3Department of Basic Sciences & Aquatic Medicine, Norwegian School of
Veterinary Science, PO Box 8146 Dep, 0033, Oslo, Norway
Full list of author information is available at the end of the article
© 2012 Thorvaldsen et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumSS, on the other hand, occurs from the sixth decade of life,
is less aggressive and only rarely metastasizes [4]. Unknown
environmental factors have been hypothesised to be part of
the pathogenesis for SE due to the observed differences in
occurrence between regions, in concert with an increase in
incidence during the past decades [5].
The difference in biological behaviour between SE and
SS is related to their various origins: SE originates from
the fetal gonocyte stage and SS from the post-pubertal
spermatogonial/spermatocytic stage [6]. Gonocytes are
recognised histologically by periodic acid-Schiff (PAS)
staining and immunohistochemistry [1]. The cells ex-
press the membrane-bound glycoprotein placental-like
alkaline phosphatase (PLAP), which can be detected
immunohistochemically with a commercial monoclonal
antibody. PAS staining detects the presence of glycogenntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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PAS positive, while the majority of SSs, which are
derived from more differentiated cells, do not express
PLAP and are PAS negative [1,7]. Immunohistochemical
detection of c-KIT protein, which is a transmembrane
tyrosine kinase receptor, is another method used for
confirming the diagnosis of SE in man. Antibodies
against c-KIT detect germinal stem cells and germinal
cells at early stages of development [8].
Testicular tumours occur more frequently in the dog
than in any other species, including man [9-11]. Sertoli
cell tumours, seminomas and interstitial cell tumours
(Leydig cell tumours) are the most common histological
types [12,13]. Because testicular tumours are frequent in
the dog and dogs also share the same environment as
man, the canine model has been suggested as a means
to investigate the effect of environmental factors on
human germ cell tumour occurrence [14].
Canine seminomas are classified according to growth
pattern [15], and classification into classical and sperma-
tocytic seminoma has not been established in veterinary
pathology. Furthermore, canine testicular germ cell
tumours generally develop in middle-aged to old dogs
[12,14,16]. On the basis of the low malignancy, low
metastatic potential and their tendency to develop in old
individuals, it has traditionally been assumed that canine
seminomas represent the counterpart to human SS [17].
However, this concept was recently challenged by three
publications in which canine seminomas were charac-
terised morphologically and by immunohistochemical
analysis for PLAP and c-KIT [16,18,19]. Grieco et al.
(2007, 2010) and Kim et al. (2010) classified 22/43 (51%)
and 8/23 (35%) of canine seminomas as SE, respect-
ively. More recently, Bush et al. (2011) morphologically
evaluated and characterised 347 canine seminomas
using diagnostic criteria from human pathology.
Immunohistochemical analysis for PLAP, c-KIT, DAZ
and DMRT-1 expression was performed and the
authors concluded that the investigated canine semino-
mas closely resembled SS [20].
If the canine model is to aid in the detection of envir-
onmental risk factors for human SE, the degree to which
the tumours compare across the two species needs to be
determined. The aim of the present study was therefore
to characterise seminoma in Norwegian dogs using
morphology and immunohistochemistry, and determine




In this cross-sectional study, 46 seminomas were
selected from the Norwegian Canine Cancer Registerbased on computer-generated random numbers. The full
dataset consisted of 214 seminomas submitted to the
diagnostic pathology service at the Norwegian School of
Veterinary Science between 1998 and 2009. The semino-
mas in this study were re-examined by an experienced
pathologist (GG) during 2010 to confirm the histopatho-
logical diagnosis. Tumours were derived from intact
dogs ranging in age from 6 to 15 years. Twenty different
breeds were represented in the material. Twelve dogs
were of either mixed or unknown origin.
Histopathology
Serial sections (3–4 μm) were obtained and stained with
HE and PAS. On the basis of their histological patterns,
seminomas were classified as intratubular or diffuse,
according to the WHO classification system for tumours
of domestic animals [15]. Seminomas showing both
intratubular and diffuse neoplastic growth were desig-
nated as “intratubular/diffuse”.
Immunohistochemistry
Immunohistochemistry was performed with PLAP and
c-KIT antibodies. The PLAP staining was performed
with a mouse monoclonal IgG antibody (Product code
M7191, Dako AS, DK-2600 Glostrup, Denmark) and
sections (3–4 μm) from formalin fixed, paraffin wax em-
bedded tissue were labelled by the avidin-biotin-peroxidase
complex (ABC) procedure with the VectastainW immuno-
peroxidase kit (Vector Laboratories, Burlingame, CA
94010, USA). The c-KIT staining was performed on similar
tissue sections, with a rabbit polyclonal antibody (Product
code A4502, Dako AS) and the EnVisionW-kit (Dako AS,
DK-2600 Glostrup, Denmark). In brief, the staining proto-
col was as follows (a detailed protocol may be obtained
from the corresponding author):
PLAP: Antigen retrieval was done by immersion of tis-
sues in a 0.5 M EDTA buffer at pH 8.0 and heating the
tissue and buffer to 92 °C for 5 minutes in a microwave
oven at 750 watts. Inhibition of endogenous peroxidase
was done with H202 in methanol. Blocking of nonspeci-
fic binding was done with equine normal serum diluted
with bovine serum albumin (BSA)/tris buffered saline
(TBS). Primary antibody was diluted 1:25 in TBS and
sections were incubated at 4 °C over-night. Sections
were then incubated for 30 minutes with biotinylated
secondary antibodies, and subsequently incubated with
ABC-complex according to kit instructions. Specific sig-
nal was developed by incubation in 3-amino-9-ethylcar-
bazole (AEC) and the sections were counterstained with
hematoxylin.
c-KIT: Antigen retrieval was done by immersion of tis-
sues in Tris/EDTA buffer at pH 9.1 and heating the tis-
sue and buffer as described for PLAP. Inhibition of
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nol and blocking of nonspecific binding was done with
caprine normal serum diluted with BSA/TBS. Primary
antibody was diluted 1:50 in BSA/TBS and sections were
incubated at room temperature for one hour. The sec-
tions were incubated for 30 minutes with polymer/HRP
labelled anti-rabbit secondary antibody (EnVisionW-kit,
Dako AS, DK-2600 Glostrup, Denmark), developed with
chromogen solution according to kit instructions and
counterstained with hematoxylin.
Specimens from human SEs were included as positive
controls in each immunohistochemical assay. Moreover,
peritubular myoid cells and smooth muscle cells of vas-
cular walls were regarded as internal positive controls
for the PLAP staining. The human SE was also used as a
negative control. In the negative controls, the primary
antibody was replaced by an isotype control (irrelevant
mouse IgG-kappa, Product code X0931, Dako AS)
diluted 1:150 for the PLAP staining and BSA/TBS buffer
for the c-KIT staining.
All histological slides were examined using a Leica
DM RXA Light microscope (Leica Microsystems AG,
Wetzlar, Germany), and digital images were captured
with a Spot RT Slider digital camera and software (Diag-
nostic Instruments Inc., Sterling Heights, MI, USA).
Digital images with annotations were assembled in
Adobe Photoshop Elements 8 Ver. 8.0 (Adobe Systems
Inc., San Jose, California, USA).
Results
Study sample
One specimen was removed from the study sample due
to artefacts after the immunohistochemical procedure.
As a result, 45 seminomas were available for further in-
vestigation. The age of one dog was unknown. The mean
age for the remaining dogs was 10.1 years. There was no
obvious breed predilection in the study sample.
Histopathology
All 45 examined seminomas had a morphology consist-
ent with SS, with strong variation in size of tumour
cells and tumour nuclei (anisocytosis and anisokaryosis),
variable coarseness of nuclear chromatin, often with
one or several distinct nucleoli, and a high mitotic
index (approximately 1–3 mitotic figures per HPF). The
cell borders were moderately distinct, and the cyto-
plasm was eosinophilic, finely granulated and occasion-
ally vacuolated. There were also scattered, degenerate
histiocytes ("starry-sky"-pattern) and multifocal lympho-
cyte infiltration (Figure 1a). Of these 45 seminomas, 24
were diffuse only, 9 were tubular only, and 12 were
both diffuse and tubular. “Starry sky”-pattern and
lymphocyte infiltrates were less apparent in intratubular
tumour tissue. Five of 45 tumours had some granular,PAS+ signal in the cytoplasm of tumour cells (Figure 1b).
Four of these cases were intratubular tumours and one
was diffuse. The tumour cells in the human seminoma,
which was used as a positive control, had a monomorphic
appearance, with minimal anisocytosis and anisokaryosis,
clear cytoplasm (HE stain) with distinct cell borders,
and a low mitotic index (Figure 1c). These cells contained
a strong granular, PAS positive cytoplasmic signal
(Figure 1d).
Immunohistochemistry
PLAP: Two of 45 sections contained scattered, focal
areas with accumulations of strongly PLAP positive
tumour cells (Figure 2a). The two positive sections were
intratubular seminomas, and both had some PAS posi-
tive granules in the tumour cell cytoplasm (see above).
All sections in the present study contained peritubular
myoid cells and perivascular smooth muscle cells with
sparse to strong positive PLAP signal (internal positive
controls). The positive control section (human SE) con-
tained areas of varying size with strong positive PLAP
signal (Figure 2b). The positive tumour cells formed a
clearly visible, focally confluent network, which indicated
a membranous staining. In addition, positive cytoplasmic
signal was seen in individual tumour cells. No positive
cells were seen in the negative control (human SE with
primary antibody substituted with an isotype matched ir-
relevant antibody, mouse IgG-kappa).
c-KIT: 32 of 44 sections showed positive staining for
c-KIT (Figure 2c), with 12 of 44 sections having no sig-
nal. The signal in the positive sections varied consider-
ably, both in distribution and strength (summarised in
Table 1). Eighteen tumours had a staining area of less
than 25% of the tumour tissue, five stained 25-50%,
seven stained 50-75%, while two had a staining area of
more than 75% of the tumour tissue. On a semiquantita-
tive scale of staining strength the sections varied from
weak (11), moderate (5), strong (8) to very strong (8).
The staining pattern also varied, with 19 tumours showing
both membranous and cytoplasmic staining, while 13
showed cytoplasmic staining only. One of the two sections
with PAS and PLAP positive, intratubular seminoma
showed strong membranous and cytoplasmic c-KIT
staining in the same cells, while the other showed only
scattered tumour cells with cytoplasmic c-KIT staining.
The positive control (human SE) stained with a very
strong signal in more than 75% of the tumour tissue
(Figure 2d). The negative control (human SE with pri-
mary antibody substituted with BSA/TBS buffer) was
blank.
Discussion
Several studies have recently been performed to deter-
mine the histological nature of canine seminomas and to
Figure 1 Histological appearance of canine seminoma observed in the present study compared with human classical seminoma.
(a) Canine seminoma with morphology consistent with human spermatocytic seminoma: anisocytosis, anisokaryosis, numerous mitotic figures
(black arrows), degenerate cells (white arrow) and multinucleate cells (arrowhead). HE. Bar, 20 μm. (b) Canine seminoma (same as in (a)). There are
scattered, PAS + granules (arrows) in the cytoplasm of many tumour cells. PAS. Bar, 20 μm. (c) Human classical seminoma displaying characteristic
monomorphic cells with clear cytoplasm. HE. Bar, 20 μm. (d) Human classical seminoma with numerous, PAS + cytoplasmic granules (arrows). PAS.
Bar, 20 μm.
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dogs as a model for human seminomas [16,18-20]. Three
of these studies classified seminomas in the dog as clas-
sical (SE) and spermatocytic (SS) seminoma by means of
morphological evaluation, PAS reaction and PLAP and
c-KIT expression. SE was found in 22/43 cases [16,18]
and 8/23 cases [19]. However, Bush et al. (2011) investi-
gated 347 canine seminomas and determined that these
were consistent with human SS based upon histological
characterization and immunohistochemical analysis
(PLAP, c-KIT, DAZ and DMRT-1).
In the present study, none of the 45 examined semino-
mas were found to be morphologically consistent with
human SE. Furthermore, no intratubular germ cell neo-
plasia unclassified (ITGCNU)/carcinoma in situ (CIS)-
like patterns of neoplastic cells were detected. These are
believed to be the early, pre-invasive stages of SE in man
and are commonly seen adjacent to fully developed SE
[1]. Two of the cases with intratubular seminoma
showed scattered clusters of strongly PLAP positive
tumour cells. In both of these cases the tumour cells
contained PAS positive cytoplasmic granules and in one
case, the PLAP+/PAS + tumour cells also stained
strongly for c-KIT. However, this tumour tissue had typ-
ical SS morphology. In the other case, only a few of thePLAP+ tumour cells were c-KIT positive, and this tissue
was also morphologically consistent with SS. According
to Ulbright et al. (1999) some SSs may show scattered
clusters of PLAP+ cells and scant PAS + staining. Thus,
due to lack of SE-morphology in these two cases, it was
concluded that they were in fact analogous to SS with an
intratubular growth pattern.
The distinction between SE and SS is important be-
cause the biological behaviour of the two seminoma
types are markedly different, resulting in differing
treatment strategies and prognostic evaluations [7].
Based on the observed differences in molecular biology
and pathological behaviour, the notion was established
that the two tumour types originate from two distinct
stages in the development of the male germinal cells:
SE from the fetal gonocyte stage and SS from the
post-pubertal spermatogonial/spermatocytic stage [6].
SE, including its precursor stage, ITGCNU/CIS, is by
far the most common type of the two in man, and con-
sequently, the cellular origin of SE has been thoroughly
investigated [21-24]. One of the first molecular markers
found for SE was PLAP. It has been firmly established
that PLAP is positive in very early differentiation stages
of male germinal cells, showing strong signals in primor-
dial germ cells, gonocytes and prespermatogonia [22].
Figure 2 Immunohistochemistry (IHC) of canine seminoma observed in the present study compared with human classical seminoma.
(a) Canine seminoma (same as in Figure 1 a). Scattered cells are strongly positive for PLAP (arrows). PLAP IHC. Bar, 20 μm. (b) Human classical
seminoma. There is a distinct reticular pattern of PLAP-staining (arrows), indicating membranous expression. PLAP IHC. Bar, 20 μm. (c) Canine
seminoma (same as in Figure 1a). There is strong cytoplasmic staining for c-KIT (arrows). c-KIT IHC. Bar, 20 μm. (d) Human classical seminoma.
Most cells show strong membranous and some cytoplasmic signal for c-KIT (arrows). c-KIT IHC. Bar, 20 μm.
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strong staining for PLAP in ITGCNU/CIS and SE tumour
cells of young adult men has led to the widely accepted
notion that these tumours originate from the above men-
tioned cell stages during fetal and/or perinatal life [23].
The early time point for development is underpinned by
the observation that most germinal cells in the first tri-
mester testes stain positive for PLAP, while positive cells
were rare in the second trimester [25]. Consistently, post-
pubertal stages of spermatogonia are PLAP negative [1].
The c-KIT marker has also been identified as a marker
for ITGCNU/CIS and SE [8]. This protein, aTable 1 The number of c-KIT positive casesa by area of stainin
immunohistochemistry in 44 canine seminomas from the Nor
Staining area # Signal stre
Weak Moderate
>75% 2 0 0
50-75% 7 0 1
25-50% 5 0 2
<25% 18 11 2
c-KIT positive 32 11 5
a12 cases were c-KIT negative and are not included in the table.
bStaining pattern. M: Membranous, C: Cytoplasmic.transmembrane tyrosine kinase receptor, and its ligand,
stem cell factor (SCF), have an important function in
directing migration and stimulating the survival of male
germinal cells, from the primordial stage to the post-
pubertal spermatogonial stages [26]. Consequently,
the c-KIT protein has been shown to be expressed be-
yond the point in germinal cell differentiation at which
PLAP expression is downgraded. Both mice and rats
express c-KIT throughout the post-pubertal stages of
A-spermatogonia [26,27].
The extensive staining of c-KIT in our material is not
in keeping with the well-established role of this proteing, signal strength and staining pattern based on c-KIT
wegian Canine Cancer Register
ngth Staining patternb
Strong Very strong MC C
0 2 2 0
4 2 5 2
2 1 4 1
2 3 8 10
8 8 19 13
Thorvaldsen et al. Acta Veterinaria Scandinavica 2012, 54:52 Page 6 of 8
http://www.actavetscand.com/content/54/1/52as a marker for SE. 32 of 44 sections (73%) showed posi-
tive staining for c-KIT, 14 (32%) of which had a staining
area of 25% or more, the staining signal varying from
moderate to very strong. This is not unlike the findings
of Bush et al. (2011), where 40% of the investigated sec-
tions were positive for c-KIT staining of the tumour cells
in neoplasms that were morphologically, and otherwise,
interpreted as SS [20]. In the study of Bush et al. (2011),
DMRT-1, a protein important in male development and
sex determination, was used to identify SS cells. Studies
in mice have shown that DMRT-1 is strongly expressed
at the A spermatogonium stage and then downgraded at
the B spermatogonium stage, regulating the entry of
spermatocytes into meiotic cell division [28]. Human
and canine SSs are strongly DMRT-1 positive, indicating
that this tumour type originates from pre-spermatocytic
stages of germinal cells [29]. Lim et al. (2011) recently
showed that human SS might have a more heteroge-
neous histogenesis than previously anticipated. Their
study shows that SS-cells may originate from several
stages of post-pubertal spermatogonia, mainly from the
late Apale spermatogonium stages and B spermatogon-
ium stages, but also, in a minority of cases from the earl-
ier Adark spermatogonium stage [30]. This suggests that
some of the stages of germinal cells that could be the
origin of SS may also express c-KIT. In several studies of
human SS, relatively high proportions of the tumours
were c-KIT positive, leading the authors in one study to
propose that at least some SS cases may develop from
fetal germ cell stages [31], while others indicated differ-
ences in specificity between antibodies used in the
immunohistochemical protocol [32]. In a study of 20 ca-
nine seminomas, 100% (20/20) were found to be strongly
positive for c-KIT, while 20% (4/20) were PLAP positive
[33]. Taken together all these results paint a somewhat
diverse picture of the expression of c-KIT in germinal
tumours. Our interpretation of the c-KIT staining in
the present study is that at least some cases of SS
may originate from male germinal cell stages in
which the expression of the c-KIT protein has not been
downgraded.
The lack of SE cases in our material is in contrast with
some similar international studies [16,18,19], but in
agreement with the traditionally held opinion that ca-
nine seminomas are predominantly of the spermatocytic
type [17,20]. There might be several factors contributing
to this discrepancy. Variability in the occurrence of tes-
ticular germ cell tumours among breeds has been
described, [14,34,35] and breed or genetic factors could
also play a role in the development of SE. The material
in the different studies is collected from submissions to
diagnostic laboratories and the breed-distribution might
not be comparable across studies due to differences in
breed popularity between countries. Furthermore,geographical differences could lead to different exposure
to environmental factors, which might also contribute to
the variability in results between studies. Finally, cur-
rently there are no standardised criteria regarding inter-
pretation of PLAP-, c-KIT- and PAS-sections of canine
seminomas. Subjective interpretation could possibly have
biased the results and contributed to apparent differ-
ences between studies. Differences in the specificity of
the antibodies used in the different studies could also
affect the results, and have been suggested in studies of
human SS [32].
The complicating factor of cross-species variation
must also be considered. Several characteristics com-
monly recognised in human SS and SE are apparently
not applicable to their canine counterparts. In the
current study, multifocal lymphocyte infiltration was
recognised in 35/45 (78%) of the diagnosed SSs. In man,
this is a common feature of SE, but not in SS [1]. c-KIT
positive tumour cells were revealed in 32/44 (73%)
examined sections, which is in discrepancy with the role
of this protein as a marker for human SE. Both these
findings are in accordance with the study of Bush et al.
(2011). The mean age for all dogs in our study was
10.1 years. The older age of affected dogs is consistent
with the human clinical presentation of SS in the 6th
decade. SE, on the other hand, occurs in younger men.
However, the age at diagnosis of SE in the study of
Grieco et al. (2007) and Kim et al. (2010) were 10.8 years
and 8.4 years, respectively. If there are indeed two types
of seminomas in dogs, both appear to develop in older
subjects. Furthermore, the malignant nature of human
SE is not frequently observed among canine seminomas,
which are generally characterised by low malignancy and
metastatic potential. On the basis of the incongruity in
characteristics recognised in human and canine semino-
mas, one might consider the possibility of canine semi-
nomas originating from other stages of development
than their human counterparts.
Conclusions
The value of canine seminoma as a model for SE in man
remains unclear. Among the 45 investigated tumours
from Norwegian dogs, none were classified as classical
seminoma based on morphological criteria consistent
with human seminomas. Regional or breed differences
in the occurrence of classical seminoma in the dog,
as well as the lack of uniform diagnostic criteria, might
explain the discrepancy between the findings in the
current study and the results presented by other
authors.
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